Dashboard
Manage Tickers

DMACDiaMedica Therapeutics Inc.

Nasdaq diamedica.com


$ 3.70 $ 0.16 (4.57 %)    

Tuesday, 07-May-2024 15:54:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 440.32 $ 0.07 (0.02 %)
DIA $ 388.70 $ 0.29 (0.07 %)
SPY $ 517.26 $ 0.57 (0.11 %)
TLT $ 90.79 $ 0.55 (0.61 %)
GLD $ 214.23 $ -0.99 (-0.46 %)
$ 3.66
$ 3.63
$ 0.00 x 0
$ 0.00 x 0
$ 3.61 - $ 3.72
$ 1.58 - $ 4.75
142,822
na
138.93M
$ 1.07
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-19-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-28-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-10-2022 06-30-2022 10-Q
8 05-04-2022 03-31-2022 10-Q
9 03-14-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
11 08-11-2021 06-30-2021 10-Q
12 05-05-2021 03-31-2021 10-Q
13 03-10-2021 12-31-2020 10-K
14 11-04-2020 09-30-2020 10-Q
15 08-11-2020 06-30-2020 10-Q
16 05-13-2020 03-31-2020 10-Q
17 03-23-2020 12-31-2019 10-K
18 11-13-2019 09-30-2019 10-Q
19 08-13-2019 06-30-2019 10-Q
20 05-13-2019 03-31-2019 10-Q
21 03-19-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

craig-hallum-assumes-diamedica-therapeutics-at-buy-announces-price-target-of-8
Craig-Hallum Assumes DiaMedica Therapeutic...
04/24/2024 17:33:22

Craig-Hallum analyst Alexander Nowak assumes DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy rating and announces Price Targ...

diamedica-therapeutics-doses-first-patient-relaunch-of-pivotal-phase-23-remedy2-trial-of-dm199-for-acute-ischemic-stroke
DiaMedica Therapeutics Doses First Patient...
04/17/2024 20:08:51

craig-hallum-maintains-buy-on-diamedica-therapeutics-lowers-price-target-to-8
Craig-Hallum Maintains Buy on DiaMedica Th...
03/21/2024 18:31:19

Craig-Hallum analyst Alexander Nowak maintains DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and lowers the price target f...

oppenheimer-reiterates-outperform-on-diamedica-therapeutics-lowers-price-target-to-6
Oppenheimer Reiterates Outperform on DiaMe...
03/21/2024 12:43:47

Oppenheimer analyst Francois Brisebois reiterates DiaMedica Therapeutics (NASDAQ:DMAC) with a Outperform and lowers the pric...

recap-diamedica-therapeutics-q4-earnings
Recap: DiaMedica Therapeutics Q4 Earnings
03/19/2024 21:25:11

diamedica-therapeutics-fy23-eps-060-vs-052-yoy-53m-cash-with-runway-to-2026
DiaMedica Therapeutics FY23 EPS $(0.60) Vs...
03/19/2024 20:31:05

Financial ResultsResearch and development (R&D) expenses increased to $13.1 million for the year ended December 31, 2023, u...

diamedica-therapeutics-q3-eps-012-beats-013-estimate
DiaMedica Therapeutics Q3 EPS $(0.12) Beat...
11/13/2023 21:57:37

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate o...

earnings-scheduled-for-november-13-2023
Earnings Scheduled For November 13, 2023
11/13/2023 11:40:53

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr...

earnings-outlook-for-diamedica-therapeutics
Earnings Outlook For DiaMedica Therapeutics
11/10/2023 17:02:09

diamedica-therapeutics-q2-eps-016-beats-018-estimate
DiaMedica Therapeutics Q2 EPS $(0.16) Beat...
08/14/2023 20:48:05

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate o...

earnings-scheduled-for-august-14-2023
Earnings Scheduled For August 14, 2023
08/14/2023 10:45:55

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per ...

benzingas-top-ratings-upgrades-downgrades-for-june-22-2023
Benzinga's Top Ratings Upgrades, Downgrade...
06/22/2023 15:02:26

oppenheimer-upgrades-diamedica-therapeutics-to-outperform-announces-7-price-target
Oppenheimer Upgrades DiaMedica Therapeutic...
06/22/2023 11:16:31

Oppenheimer analyst Francois Brisebois upgrades DiaMedica Therapeutics (NASDAQ:DMAC) from Perform to Outperform and announce...

diamedica-raises-375m-via-equity-offering-aiding-development-activities-for-dm199
DiaMedica Raises $37.5M Via Equity Offerin...
06/21/2023 15:40:11

DiaMedica Therapeutics Inc. (NASDAQ: DMAC) has entered into an agreement with accredited investors that have agreed to provide ...

diamedica-therapeutics-announces-375m-private-placement-of-11011406-common-shares-at-a-purchase-price-of-340share
DiaMedica Therapeutics Announces $37.5M Pr...
06/21/2023 12:42:03

DiaMedica Therapeutics Inc. (NASDAQ:DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments fo...

diamedica-therapeutics-announces-that-the-fda-has-removed-the-clinical-hold-on-dm199-phase-23-trial-for-ischemic-stroke
DiaMedica Therapeutics Announces That The ...
06/21/2023 12:16:48

DiaMedica Therapeutics Inc. (NASDAQ:DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments fo...

diamedica-therapeutics-included-in-response-to-fda-is-protocol-amendment-to-incorporate-reduced-dose-for-intravenous-administration-of-dm199
Diamedica Therapeutics Included In Respons...
05/22/2023 21:18:11

- 8K Filing 

filed-on-may-19-diamedica-therapeutics-a-complete-clinical-hold-response-with-fda-for-clinical-hold-on-a-phase-23-clinical-trial-of-dm199-response-with-fda-requesting-clinical-hold-imposed-on-phase-23-clinical-trial-of-dm199-for-ais-be-lifted
Filed On May 19, DiaMedica Therapeutics A ...
05/22/2023 21:17:44

On May 22, 2023, DiaMedica Therapeutics Inc. (the "Company") announced that the Company filed on May 19, 2023 a complet...

diamedica-therapeutics-q1-eps-020-misses-016-estimate
DiaMedica Therapeutics Q1 EPS $(0.20) Miss...
05/15/2023 20:32:38

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate...

earnings-scheduled-for-may-15-2023
Earnings Scheduled For May 15, 2023
05/15/2023 09:32:35

Companies Reporting Before The Bell • Caledonia Mining (AMEX:CMCL) is expected to report earnings for its first quarter. • So...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION